🇪🇺September 26, 2026·3d agoResearchTier 2 · Direct publisher

Real-world safety and clinical outcomes of apixaban in patients with cancer and atrial fibrillation

Publisher

Europe PMC

This page provides publisher metadata, and related coverage to support discovery before sending readers to the publisher's original article.

Read original

At a glance

Publisher: Europe PMC
Region: EU
Scope: Research
Published: September 26, 2026
Language: EN

Publisher context, original article off-platform

This page presents the title, publisher metadata, and related coverage. The publisher did not provide a public summary in this feed. Full-text reading stays on the publisher's original site.

Source route

Continue on europepmc.org

Leave the platform to read the original full article on the publisher site.

Source: Europe PMC

Scope: Research

Evidence: Tier 2 · Direct publisher

Open original article

Related coverage

More related coverage

Universitätsspital Zürich (USZ)/4h ago

Drei Leuchtturmprojekte für präzisere Therapien

Hospital Clínic de Barcelona/5h ago

The HCB-IDIBAPS Biobank has obtained ISO 20387 accreditation, the leading international standard of excellence and quality

UNMC/6h ago

Universidad Anahuac leaders visit UNMC